Health
COVID-19 series: The year of the vaccine
The year 2021 began with governments racing to obtain, and administer, COVID-19 shots produced by some of the pharmaceutical industry’s...
Qiagen shares hit 21-year high following Reuters exclusive...
Reuters reported exclusively that German genetic testing company Qiagen sees upside potential for its full-year guidance and expects...
Reuters first to report Syngenta’s $10 billion IPO
Reuters was first to report that ChemChina is aiming to raise around $10 billion from a Shanghai IPO for Swiss […] The post Reuters...
Reuters exclusively reports South Korea offers to produce...
Reuters reported exclusively that South Korea is in talks with mRNA vaccine makers, including Pfizer and Moderna, to produce COVID-19...
Reuters exclusively reports prenatal test developed with...
Reuters exclusively reported that a prenatal test taken by millions of pregnant women globally was developed by Chinese gene company...
Reuters exclusively reports in boost for Africa, Senegal...
Reuters exclusively reported that Senegal could begin producing COVID-19 vaccines next year under an agreement with Belgian biotech...
Reuters exclusively reports Eli Lilly memo says firm did...
Reuters reported exclusively that a week before Eli Lilly disclosed to regulators that the U.S. Justice Department was investigating...
Reuters exclusively reports some countries are using vaccines...
Reuters exclusively reported that British foreign minister Dominic Raab said that there was no doubt some countries were using vaccines...
Reuters exclusively reports PAI Partners close to acquiring...
Reuters reported exclusively that private equity firm PAI Partners is in final talks to buy France’s SGD Pharma, a firm […] The post...
Reuters exclusively reports India may raise vaccine spending...
After Indian Prime Minister Narendra Modi said in an address to the nation that the federal government would bear the […] The post...
Reuters exclusively reports Latin America poised to benefit...
Reuters exclusively reported that Latin America is poised to receive millions of U.S-made COVID-19 shots in the coming weeks as […]...
Reuters first to report India’s most populous state to...
Reuters was first to report that India’s most populous state will spend up to $1.36 billion to buy COVID-19 shots […] The post Reuters...
Reuters exclusively reports G20 snubs COVID patent waiver,...
Reuters reported exclusively that leaders of the world’s largest economies back “voluntary licensing” of COVID-19 vaccine patents,...
Reuters reveals India unlikely to resume sizable COVID-19...
Reuters was first to report that India is unlikely to resume major exports of COVID-19 vaccines until at least October […] The post...
Reuters exclusively reports Lilly hit by staff accusations,...
Reuters exclusively reported that Eli Lilly & Co employees have accused a factory executive of altering documents required by government...
Reuters exclusively reports UNICEF says AstraZeneca supply...
Reuters exclusively reported that problems that have delayed AstraZeneca supplies to the COVAX vaccine-sharing facility have been...
